1 completed, 1 not yet recruiting, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Withdrawn 1 |
Follow Venezuelan Equine Encephalitis: new trials by email Literature Review of Venezuelan Equine Encephalitis trials Research Report on Venezuelan Equine Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Not yet recruiting | Medigen, Inc. | 39 | 2025-08-15 | 2025-07-28 |
| VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2019-04-02 | 2021-03-24 |
| Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine VEE 3526 - Venezuelan Equine Encephalitis | Phase 1 | Withdrawn | DynPort Vaccine Company LLC, A GDIT Company | 2005-07-01 | 2015-09-18 |
Encephalomyelitis, Venezuelan Equine (3) · Alphavirus Infections (1) · Encephalomyelitis, Eastern Equine (1) · Encephalomyelitis, Western Equine (1)
Arbovirus Infections (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Central Nervous System Viral Diseases (3) · Encephalitis (3) · Encephalitis, Arbovirus (3) · Encephalitis, Viral (3) · Encephalomyelitis (3) · Encephalomyelitis, Equine (3) · Infections (3) · Infectious Encephalitis (3) · Mosquito-Borne Diseases (3) · Nervous System Diseases (3) · Neuroinflammatory Diseases (3)
aluminum sulfate (1)
DynPort Vaccine Company LLC, A GDIT Company (1) · Medigen, Inc. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3)
Grace Chen, MD (1) · Julie E Ledgerwood, DO (1)